Caribou Biosciences (CRBU) Assets Average: 2021-2025
Historic Assets Average for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $207.9 million.
- Caribou Biosciences' Assets Average fell 42.02% to $207.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.9 million, marking a year-over-year decrease of 42.02%. This contributed to the annual value of $372.8 million for FY2024, which is 7.50% down from last year.
- Per Caribou Biosciences' latest filing, its Assets Average stood at $207.9 million for Q3 2025, which was down 15.91% from $247.3 million recorded in Q2 2025.
- Caribou Biosciences' Assets Average's 5-year high stood at $452.2 million during Q4 2021, with a 5-year trough of $207.9 million in Q3 2025.
- For the 3-year period, Caribou Biosciences' Assets Average averaged around $345.7 million, with its median value being $358.6 million (2024).
- Its Assets Average has fluctuated over the past 5 years, first spiked by 32.21% in 2022, then tumbled by 42.02% in 2025.
- Caribou Biosciences' Assets Average (Quarterly) stood at $452.2 million in 2021, then declined by 14.57% to $386.3 million in 2022, then increased by 15.16% to $444.9 million in 2023, then fell by 26.08% to $328.8 million in 2024, then tumbled by 42.02% to $207.9 million in 2025.
- Its last three reported values are $207.9 million in Q3 2025, $247.3 million for Q2 2025, and $293.5 million during Q1 2025.